Tobias Jeffrey K
EVP, R&D & CMO at JAZZ; EVP Research & Dev & CMO at NeurogesX Inc
- Sold, on record
- $7.1M
- Dollars the filings state
- Form 4 sales
- 21
- Latest Feb 10, 2015
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- JAZZJazz Pharmaceuticals plcEVP, R&D & CMO
- NeurogesX IncEVP Research & Dev & CMO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- JAZZ54,289 shares
- NeurogesX Inc27,114 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale JAZZPlan not statedMay 16, 2014 2014
Sold 1,000 shares at $128.01 ($128k)
Tobias Jeffrey K, EVP, Research & Dev and CMO
Sold 2.1% of holdings ($6.2M position)47,103 shares left0.3x usual sizeFiling
- 2 Form 4 sale JAZZPlan not statedJun 9, 2014 +24 days
Sold 3,000 shares at $146.24 ($439k)
Tobias Jeffrey K, EVP, Research & Dev and CMO
Sold 6% of holdings ($7.3M position)47,103 shares left1x usual sizeFiling
- 3 Form 4 sale JAZZPlan not statedAug 11, 2014 +63 days
Sold 4,933 shares at $135.42 ($668k)
Tobias Jeffrey K, EVP, Research & Dev and CMO
Sold 10.4% of holdings ($6.4M position)42,538 shares left1.6x usual sizeFiling
- 4 Form 4 sale JAZZPlan not statedSep 12, 2014 +32 days
Sold 1,000 shares at $171.22 ($171k)
Tobias Jeffrey K, EVP, Research & Dev and CMO
Sold 2.4% of holdings ($7.3M position)41,538 shares left0.3x usual sizeFiling
- 5 Form 4 sale JAZZPlan not statedOct 10, 2014 +28 days
Sold 1,000 shares at $154.04 ($154k)
Tobias Jeffrey K, EVP, Research & Dev and CMO
Sold 2.4% of holdings ($6.4M position)40,538 shares left0.3x usual sizeFiling
- 6 Form 4 sale JAZZPlan not statedNov 14, 2014 +35 days
Sold 1,000 shares at $173.32 ($173k)
Tobias Jeffrey K, EVP, Research & Dev and CMO
Sold 2.5% of holdings ($7M position)39,538 shares left0.3x usual sizeFiling
- 7 Form 4 sale JAZZPlan not statedNov 24, 2014 +10 days
Sold 4,598 shares at $170.12 ($782k)
Tobias Jeffrey K, EVP, Research & Dev and CMO
Sold 11.6% of holdings ($6.7M position)34,940 shares left1.5x usual sizeFiling
- 8 Form 4 sale JAZZPlan not statedFeb 10, 2015 +78 days
Sold 5,000 shares at $166.82 ($834k)
Tobias Jeffrey K, EVP, R&D & CMO
Sold 12.5% of holdings ($6.7M position)35,063 shares left1.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2015 | Feb 12, 2015 | JAZZ | EVP, R&D & CMO | Form 4 sale | 5,000 | $834k | 12.5% | Plan not stated | SEC |
| Nov 24, 2014 | Nov 25, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 4,598 | $782k | 11.6% | Plan not stated | SEC |
| Nov 14, 2014 | Nov 18, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 1,000 | $173k | 2.5% | Plan not stated | SEC |
| Oct 10, 2014 | Oct 14, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 1,000 | $154k | 2.4% | Plan not stated | SEC |
| Sep 12, 2014 | Sep 15, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 1,000 | $171k | 2.4% | Plan not stated | SEC |
| Aug 11, 2014 | Aug 13, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 4,933 | $668k | 10.4% | Plan not stated | SEC |
| Jun 9, 2014 | Jun 11, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 3,000 | $439k | 6.0% | Plan not stated | SEC |
| May 16, 2014 | May 20, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 1,000 | $128k | 2.1% | Plan not stated | SEC |
| Apr 14, 2014 | Apr 16, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 3,000 | $386k | 5.9% | Plan not stated | SEC |
| Mar 10, 2014 | Mar 12, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 3,000 | $459k | 5.9% | Plan not stated | SEC |
| Feb 27, 2014 | Mar 3, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 3,000 | $496k | 6.7% | Plan not stated | SEC |
| Feb 10, 2014 | Feb 12, 2014 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 2,560 | $391k | 5.4% | Plan not stated | SEC |
| Dec 9, 2013 | Dec 11, 2013 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 1,325 | $156k | 2.9% | Plan not stated | SEC |
| Nov 11, 2013 | Nov 13, 2013 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 2,373 | $234k | 5.1% | Plan not stated | SEC |
| Oct 14, 2013 | Oct 16, 2013 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 5,000 | $413k | 10.1% | Plan not stated | SEC |
| Sep 9, 2013 | Sep 10, 2013 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 5,000 | $436k | 10.1% | Plan not stated | SEC |
| Aug 12, 2013 | Aug 13, 2013 | JAZZ | EVP, Research & Dev and CMO | Form 4 sale | 7,500 | $606k | 14.4% | Plan not stated | SEC |
| May 18, 2011 | May 19, 2011 | NeurogesX Inc | EVP Research & Dev & CMO | Form 4 sale | 2,448 | $7k | 32.9% | Unusual | SEC |
| May 16, 2011 | May 16, 2011 | NeurogesX Inc | EVP Research & Dev & CMO | Form 4 sale | 2,666 | $8k | 26.4% | Unusual | SEC |
| Nov 30, 2009 | Dec 1, 2009 | NeurogesX Inc | Chief Medical Officer | Form 4 sale | 12,077 | $97k | 64.4% | Unusual | SEC |
| Nov 27, 2009 | Nov 30, 2009 | NeurogesX Inc | Chief Medical Officer | Form 4 sale | 9,923 | $83k | 59.8% | Unusual | SEC |